Dysregulation of Gene Expression in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Mouse Substantia Nigra

Parkinson's disease pathogenesis proceeds through several phases, culminating in the loss of dopaminergic neurons of the substantia nigra (SN). Although the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of oxidative SN injury is frequently used to study degeneration of dopaminergic...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Neurosci
Päätekijät: Miller, Renee M., Callahan, Linda M., Casaceli, Cindy, Chen, Linlin, Kiser, Gretchen L., Chui, Buena, Kaysser-Kranich, Tamma M., Sendera, Timothy J., Palaniappan, Chockalingam, Federoff, Howard J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Society for Neuroscience 2004
Aiheet:
Neurobiology of Disease
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6729635/
https://ncbi.nlm.nih.gov/pubmed/15329391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.4204-03.2004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia